AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 294: H793-H800, 2008. First published November 30, 2007; doi:10.1152/ajpheart.01229.2007
0363-6135/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/H793    most recent
01229.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Tsujimae, K.
Right arrow Articles by Kurachi, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsujimae, K.
Right arrow Articles by Kurachi, Y.

In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling

Kenji Tsujimae,1 Shingo Murakami,1,2 and Yoshihisa Kurachi1,2

1Division of Molecular and Cellular Pharmacology, Department of Pharmacology, Graduate School of Medicine, and 2The Center for Advanced Medical Engineering and Informatics, Osaka University, Osaka, Japan

Submitted 23 October 2007 ; accepted in final form 30 November 2007

Pharmacological treatment with various antiarrhythmic agents for the termination or prevention of atrial fibrillation (AF) is not yet satisfactory. This is in part because the drugs may not be sufficiently selective for the atrium, and they often cause ventricular arrhythmias. The ultrarapid-delayed rectifying potassium current (IKur) is found in the atrium but not in the ventricle, and it has been recognized as a potentially promising target for anti-AF drugs that would be without ventricular proarrhythmia. Several new agents that specifically block IKur have been developed. They block IKur in a voltage- and time-dependent manner. Here we use mathematical models of normal and electrically remodeled human atrial action potentials to examine the effects of the blockade kinetics of IKur on atrial action potential duration (APD). It was found that after AF remodeling, an IKur blocker with fast onset can effectively prolong APD at any stimulus frequency, whereas a blocker with slow onset prolongs APD in a frequency-dependent manner only when the recovery is slow. The results suggest that the voltage and time dependence of IKur blockade should be taken into account in the testing of anti-AF drugs. This modeling study suggests that a simple voltage-clamp protocol with a short pulse of ~10 ms at 1 Hz may be useful to identify the effective anti-AF drugs among various IKur blockers.

ultrarapid-delayed rectifying potassium current; atrial action potential; computer simulation



Address for reprint requests and other correspondence: Y. Kurachi, Div. of Molecular and Cellular Pharmacology, Dept. of Pharmacology, Graduate School of Medicine, Osaka Univ., 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan (e-mail: ykurachi{at}pharma2.med.osaka-u.ac.jp)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.